World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
104
Citations
33695
World Ranking
470
National Ranking
264

Overview

Gary L. Johnson is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research spans across multiple fields within medicine and biochemistry, genetics, and molecular biology, with a significant focus on molecular biology, oncology, and neurology.

Their scholarly output includes 107 publications related to medicine and 93 in biochemistry, genetics, and molecular biology. Within these, notable subfields of study are molecular biology (61 publications), oncology (28), neurology (22), cancer research (17), and organic chemistry (14).

Johnson's main research topics encompass:

  • Melanoma and MAPK Pathways
  • Neurofibromatosis and Schwannoma Cases
  • Cancer Genomics and Diagnostics
  • Protein Degradation and Inhibitors
  • Phagocytosis and Immune Regulation
  • Neuroblastoma Research and Treatments
  • Cancer Mechanisms and Therapy

Frequent coauthors in Johnson's collaborative work include Michael P. East, Steven P. Angus, Christopher R. M. Asquith, Timothy J. Stuhlmiller, and Shawn M. Gomez.

Publications have been distributed across various venues, with the highest number appearing in UNC Libraries (54), followed by Cancer Research (10), bioRxiv (Cold Spring Harbor Laboratory) (8), Neuro-Oncology (3), and the Journal of Biological Chemistry (2).

Selected recent papers illustrate the focus of Johnson's research:

  • FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease, 2020, Journal of Clinical Investigation
  • Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial, 2021, Nature Medicine
  • New strategies for targeting kinase networks in cancer, 2021, Journal of Biological Chemistry
  • Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK, 2021, PLoS ONE
  • Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy, 2020, JCI Insight

Best Publications

  • Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

    James S. Duncan;Martin C. Whittle;Kazuhiro Nakamura;Amy N. Abell

  • Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation

    Daniel R. Ambruso;Cindy Knall;Amy N. Abell;Julie Panepinto

  • Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death.

    Nancy Lassignal Johnson;Anne M. Gardner;Katrina M. Diener;Carol A. Lange-Carter

  • Sequential protein kinase reactions controlling cell growth and differentiation

    Gary L. Johnson;Richard R. Vaillancourt

  • Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption.

    Toshiaki Yujiri;Susan Sather;Gary R. Fanger;Gary L. Johnson

  • MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases?

    Gary R Fanger;Pär Gerwins;Christian Widmann;Matthew B Jarpe

  • Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases

    Cindy Knall;G. Scott Worthen;G. Scott Worthen;Gary L. Johnson

  • Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation.

    B E Wadzinski;W H Wheat;S Jaspers;L F Peruski

  • Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model

    Robert S. Stearman;Lori Dwyer-Nield;Laura Zerbe;Stacy A. Blaine

  • Unexplored therapeutic opportunities in the human genome.

    Tudor I. Oprea;Cristian G. Bologa;Søren Brunak;Allen Campbell

  • Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.

    J A Nick;N J Avdi;S K Young;C Knall

  • Role of mitogen-activated protein kinase kinase kinases in signal integration.

    B D Cuevas;A N Abell;G L Johnson

  • Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils

    Jerry A. Nick;Jerry A. Nick;Natalie J. Avdi;Scott K. Young;Lisa A. Lehman

  • Cloning of a Novel Mitogen-activated Protein Kinase Kinase Kinase, MEKK4, That Selectively Regulates the c-Jun Amino Terminal Kinase Pathway

    Pär Gerwins;Jonathan L. Blank;Gary L. Johnson

  • Structural and evolutionary division of phosphotyrosine binding (PTB) domains.

    Mark T. Uhlik;Brenda Temple;Sompop Bencharit;Adam J. Kimple

  • Involvement of Ras and Raf in the Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase.

    S. Winitz;M. Russell;Nan-Xin Qian;A. Gardner

  • Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

    Timothy J. Stuhlmiller;Samantha M. Miller;Jon S. Zawistowski;Kazuhiro Nakamura

  • MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation

    Toshiaki Yujiri;Margaret Ware;Margaret Ware;Christian Widmann;Christian Widmann;Ryan Oyer

  • MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts.

    S K Gupta;C Gallego;G L Johnson;L E Heasley

  • CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis

    Jon S. Zawistowski;Lisa Stalheim;Mark T. Uhlik;Amy N. Abell

Frequent Co-Authors

Lee M. Graves
Lee M. Graves University of North Carolina at Chapel Hill
Erwin W. Gelfand
Erwin W. Gelfand University of Colorado Anschutz Medical Campus
Lynn E. Heasley
Lynn E. Heasley University of Colorado Anschutz Medical Campus
H. Shelton Earp
H. Shelton Earp University of North Carolina at Chapel Hill
Frank B. Furnari
Frank B. Furnari University of California, San Diego
Joel S. Parker
Joel S. Parker University of North Carolina at Chapel Hill
Naohiro Terada
Naohiro Terada University of Florida
Michael E. Berens
Michael E. Berens Translational Genomics Research Institute
Stephen V. Frye
Stephen V. Frye University of North Carolina at Chapel Hill
Marsha Rich Rosner
Marsha Rich Rosner University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology often sparks interest in other dynamic fields. If you’re looking for diverse academic routes, there are plenty of online programs that can complement your passion for science. For example, those interested in environmental sciences or structural biology may benefit from an online architecture degree, which blends creativity and problem-solving with scientific principles.

Analytical thinkers might consider an online math bachelor's degree to strengthen quantitative skills relevant to bioinformatics or research data analysis. For students creatively inclined, a graphic design online degree can open career paths in scientific illustration, medical imaging, and science communication.

Budget-conscious learners should also explore online interdisciplinary studies tuition costs to find flexible, affordable options that merge molecular biology with other interests. Each of these online degrees offers valuable skills to broaden your career pathways, making it easier than ever to tailor your education to your goals.

Best Scientists Citing Gary L. Johnson

Trending Scientists